Q2 2026 saw 10.2% revenue growth, driven by strong organic sales, successful acquisitions, and robust performance across all segments. Profitability remained solid despite margin normalization in Vitapro, and guidance was updated to mid to high single-digit revenue growth for the year.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.